Deimante Tamkus is an Oncology physician affiliated with Cook County Health and Hospitals System. OpenAlex indexes 49 publications with 2,166 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1950 W Polk St
Chicago, IL 606123723
Telephone
312-864-6000Provider last certified this registry record 30 Apr 2021.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20252 payments
- PFIZER INC.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
70.6%Aromatase Inhibitor41.2%Anastrozole100%Part D≥13 patientsKinase inhibitor29.4%Ibrance56%Inlyta44%Part D<11 patientsMetabolism & gastrointestinal
15.3%Serotonin-3 Receptor Antagonist15.3%Ondansetron Hcl100%Part D<11 patientsNervous system
14.1%SNRI14.1%Duloxetine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Stroger Hospital of Cook County (SHCC) NCORP
Cook County Health and Hospital System
FY2025$916,936UG1CA190000 - Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
Hektoen Institute for Medical Research
FY2024$410,325UG1CA190000 - Stroger Hospital of Cook County (SHCC) MU-NCORP
Cook County Health and Hospital System
FY2024$347,857UG1CA190000
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Engendering Reproductive Health Within Oncologic Survivorship Trial, ECOG-ACRIN E1Q11
JCO Oncology Practice
2026 - Abstract A018: Examination of longitudinal changes in work ability by race and income in men undergoing curative treatment for prostate cancer (PCW-1802)
Cancer Epidemiology Biomarkers & Prevention
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Lad, MD
Cook County Health and Hospitals System
Leon Fogelfeld, MD
Cook County Health and Hospitals System
Grzegorz Pietrasik, MD
Cook County Health and Hospitals System
Katayoun Rezai, MD
Cook County Health and Hospitals System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”